Developer docs
API playgroundTry for free, no card

Search company profiles

Bionabu

Full company profile

uuid000k774

Namestring
Bionabu
Websiteurl
bionabu.com
Company typeenum
Private
Founded yearint
2021
Short descriptiontext

Bionabu is a London-based clinical trial integrity software company serving pharmaceutical and biotech sponsors. Its platform combines pediatric patient preparation (PrepStoriesAI®), content governance (Vera Content), and protocol deviation management (Vera Deviate).

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
clinical trial integrity, patient preparation platform, content governance software, protocol deviation management, pediatric clinical trials
Industry3 codes
1Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
CodeHLAGAJAMPrimaryYes
2Regulatory Submissions & Clinical Content Management (eCTD/Publishing)
CodeHLACAOANPrimaryNo
3Regulatory Strategy & IND/NDA/BLA Submissions Support
CodeHLAIALAHPrimaryNo
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Clinical Trial Management Software
Social media profiles2 records
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Bionabu operates a Clinical Trial Integrity Platform that integrates pediatric patient preparation content, content governance, and protocol deviation management into a single system for clinical trial sponsors. The platform includes PrepStoriesAI® with The Child Metaphor Bank™, Vera Content for communication governance, Vera Deviate for deviation control, and a Readiness Framework for clinical operations assessment.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Bionabu offers a unified Clinical Trial Integrity Platform designed to ensure compliance and quality from patient understanding through regulatory inspection. The platform consists of multiple integrated modules: PrepStoriesAI® (for pediatric patient preparation with The Child Metaphor Bank™), Vera Content (for content governance), and Vera Deviate (for protocol deviation control), all working together to prepare patients, govern content, and control deviations throughout the clinical trial lifecycle.

Product and service1 record
1PrepStoriesAI®
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Life sciences R&D platform spanning clinical trial management, regulatory, safety, and content workflows. Competes with Bionabu on the regulatory-grade content and trial integrity narrative.

TypeEmerging player
Description

Patient recruitment and engagement services for clinical trials, including pediatric populations. Adjacent to Bionabu's patient preparation wedge — competes for sponsor patient-engagement budget with a services-led model.

TypeDirect peer
Description

Clinical trial technology vendor combining eCOA, imaging, and endpoint adjudication. Overlaps with Bionabu on patient-facing clinical software purchased by pharma/biotech sponsors.

TypeDirect peer
Description

Provider of eCOA, ePRO, and patient engagement solutions for clinical trials. Directly comparable in patient-facing clinical software sold to pharma sponsors, including pediatric-population support.

TypeDirect peer
Description

Dominant cloud-platform provider for pharma clinical, regulatory, and quality operations (Veeva Vault, CDB, CTMS). Competes directly with Bionabu's clinical content governance and trial integrity positioning across pharma sponsors.

TypeDirect peer
Description

Cloud EDC and decentralized trial platform used by sponsors and CROs. Comparable to Bionabu in providing trial-configurable clinical software infrastructure to pharma and academic sponsors.

TypeDirect peer
Description

Provider of the Rave EDC/CTMS/eCOA platform used in a large share of clinical trials. Overlaps with Bionabu on eCOA-style patient-facing clinical software for sponsors and CROs globally.

TypeDirect peer
Description

eCOA, ePRO, and patient engagement platform for clinical trials. Direct overlap with Bionabu's patient-facing clinical software modules sold to pharma sponsors and CROs.

TypeDirect peer
Description

Decentralized clinical trial platform offering eCOA, ePRO, and patient engagement tools. Comparable to Bionabu in delivering patient-facing trial infrastructure to sponsors across geographies.

TypeDirect peer
Description

Oracle's unified clinical trial platform covering EDC, RTSM, CTMS, and eCOA. Competes with Bionabu's integrated approach to trial integrity across the same enterprise pharma buyer base.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bionabu

Clinical Trial Management Softwarebionabu.com

Bionabu is a London-based clinical trial integrity software company serving pharmaceutical and biotech sponsors. Its platform combines pediatric patient preparation (PrepStoriesAI®), content governance (Vera Content), and protocol deviation management (Vera Deviate).

Bionabu firmographics

Firmographics
Name
Bionabu
Website
https://bionabu.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Bionabu is a London-based clinical trial integrity software company serving pharmaceutical and biotech sponsors. Its platform combines pediatric patient preparation (PrepStoriesAI®), content governance (Vera Content), and protocol deviation management (Vera Deviate).
Ownership category
akta.pro rank

Bionabu industry classification

Industry
Product category
Clinical Trial Management Software
SIC
Services-Prepackaged Software (7372)
akta.pro primary industry
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
akta.pro secondary industries
Regulatory Submissions & Clinical Content Management (eCTD/Publishing) (HLACAOAN), Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)

Keywords

  • Clinical trial integrity
  • Patient preparation platform
  • Content governance software
  • Protocol deviation management
  • Pediatric clinical trials

Where Bionabu is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

Bionabu business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Distribution channels1 record

Marketing channels2 records

Bionabu product offering

Product offering

Core offering

Bionabu operates a Clinical Trial Integrity Platform that integrates pediatric patient preparation content, content governance, and protocol deviation management into a single system for clinical trial sponsors. The platform includes PrepStoriesAI® with The Child Metaphor Bank™, Vera Content for communication governance, Vera Deviate for deviation control, and a Readiness Framework for clinical operations assessment.

Product overview

Bionabu offers a unified Clinical Trial Integrity Platform designed to ensure compliance and quality from patient understanding through regulatory inspection. The platform consists of multiple integrated modules: PrepStoriesAI® (for pediatric patient preparation with The Child Metaphor Bank™), Vera Content (for content governance), and Vera Deviate (for protocol deviation control), all working together to prepare patients, govern content, and control deviations throughout the clinical trial lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

  • PrepStoriesAI®

Companies that use Bionabu

Customer profile

Segments1 record

Ideal customer profiles1 record

Bionabu technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Bionabu partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Bionabu competitors and assessment

Company assessment

Direct peers

  • ArisGlobal: Life sciences R&D platform spanning clinical trial management, regulatory, safety, and content workflows. Competes with Bionabu on the regulatory-grade content and trial integrity narrative.
  • Clario: Clinical trial technology vendor combining eCOA, imaging, and endpoint adjudication. Overlaps with Bionabu on patient-facing clinical software purchased by pharma/biotech sponsors.
  • Signant Health: Provider of eCOA, ePRO, and patient engagement solutions for clinical trials. Directly comparable in patient-facing clinical software sold to pharma sponsors, including pediatric-population support.
  • Veeva Systems: Dominant cloud-platform provider for pharma clinical, regulatory, and quality operations (Veeva Vault, CDB, CTMS). Competes directly with Bionabu's clinical content governance and trial integrity positioning across pharma sponsors.
  • Castor: Cloud EDC and decentralized trial platform used by sponsors and CROs. Comparable to Bionabu in providing trial-configurable clinical software infrastructure to pharma and academic sponsors.
  • Medidata (Dassault Systèmes): Provider of the Rave EDC/CTMS/eCOA platform used in a large share of clinical trials. Overlaps with Bionabu on eCOA-style patient-facing clinical software for sponsors and CROs globally.
  • Clinical Ink: eCOA, ePRO, and patient engagement platform for clinical trials. Direct overlap with Bionabu's patient-facing clinical software modules sold to pharma sponsors and CROs.
  • THREAD: Decentralized clinical trial platform offering eCOA, ePRO, and patient engagement tools. Comparable to Bionabu in delivering patient-facing trial infrastructure to sponsors across geographies.
  • Oracle Clinical One: Oracle's unified clinical trial platform covering EDC, RTSM, CTMS, and eCOA. Competes with Bionabu's integrated approach to trial integrity across the same enterprise pharma buyer base.

Emerging players

  • BBK Worldwide: Patient recruitment and engagement services for clinical trials, including pediatric populations. Adjacent to Bionabu's patient preparation wedge — competes for sponsor patient-engagement budget with a services-led model.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

Bionabu social profiles

Digital presence

Bionabu financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bionabu leadership team

Management profile

Number of profiles

Bionabu funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bionabu M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bionabu

What does Bionabu do?

Bionabu operates a Clinical Trial Integrity Platform that integrates pediatric patient preparation content, content governance, and protocol deviation management into a single system for clinical trial sponsors. The platform includes PrepStoriesAI® with The Child Metaphor Bank™, Vera Content for communication governance, Vera Deviate for deviation control, and a Readiness Framework for clinical operations assessment.

Is Bionabu a public or private company?

Bionabu is a private company. It is classified as unknown and is currently operating.

When was Bionabu founded?

Bionabu was founded in 2021. It employs 11 to 50 people.

Where is Bionabu based?

Bionabu is headquartered in London, United Kingdom, in the Europe region.

Who are Bionabu's main competitors?

Direct peers on record are ArisGlobal, Clario, Signant Health, Veeva Systems, Castor, Medidata (Dassault Systèmes), Clinical Ink, THREAD and Oracle Clinical One. BBK Worldwide is listed as an emerging player.

Does Bionabu have an API?

No public API is recorded for Bionabu.

What industry is Bionabu in?

Bionabu's product category is Clinical Trial Management Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAOAN, Regulatory Submissions & Clinical Content Management (eCTD/Publishing). Its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales